Epivir is an antiviral medication classified as a nucleoside analog reverse transcriptase inhibitor. It is used primarily for the treatment of chronic hepatitis b infection and as part of combination therapy for hiv. The drug works by entering infected cells and being phosphorylated to its active triphosphate form. This active metabolite competes with endogenous deoxyadenosine triphosphate incorporating into viral dna and terminating chain elongation. Incorporation prevents further dna synthesis leading to viral genome truncation and loss of infectivity. In host cells the damaged viral genome cannot replicate while normal cellular dna repair pathways do not recognize the incorporated analog. As a result Epivir reduces viral load and helps control disease progression without directly destroying host cells.

Epivir is a nucleoside analog indicated for the treatment of chronic hepatitis b and infection with the human immunodeficiency virus. It works by mimicking one of the building blocks of viral genetic material and thus interfering with the virus's ability to replicate. Once inside infected cells it is phosphorylated to its active form lamivudine triphosphate, which binds to the viral reverse transcriptase enzyme. This binding prevents the enzyme from converting viral rna into dna, stopping the production of new viral particles. As a result the amount of virus in the bloodstream declines, which helps to control disease progression. The drug also has activity against certain polymerase enzymes in hepatitis b virus, providing antiviral effect in that infection as well. Its oral administration allows for convenient dosing and consistent plasma concentrations that support long-term therapy.

Common side effects of Epivir include nausea, headache, and fatigue. Some people may develop a mild skin rash or experience dizziness. Insomnia and loss of appetite are also reported. These reactions are generally mild and often improve without intervention. Severe side effects such as significant liver dysfunction are rare. Monitoring symptoms helps determine when further evaluation may be needed.

Epivir can cause headache in some patients. It may also lead to fatigue or weakness. Nausea and vomiting are occasionally reported. Abdominal pain or discomfort can occur. Skin reactions such as rash are possible. Changes in liver function have been observed in a small number of cases. Diarrhea is sometimes noted. These effects are generally mild and may resolve with continued use.